Studi clinici su BPCO nello stato di Alabama
21 studi su BPCO cercano partecipanti presso sedi nello stato di Alabama.
Città nello stato di Alabama
Testo ufficiale dello studio (inglese)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
In reclutamentoFase 2
Età da 40 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
In reclutamentoFase 4
Età da 40 a 85 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
In reclutamentoFase 2/3
Età da 35 a 80 · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
In reclutamentoStudio osservazionale
Età da 50 a 99 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
In reclutamentoFase 3
Età 40 e oltre · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
In reclutamento
Età 22 e oltre · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 30 a 55 · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
In reclutamento
Età da 40 a 80 · Tutti i sessi · Aggiornato il 28 apr 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
In reclutamento
Età da 40 a 84 · Tutti i sessi · Aggiornato il 24 apr 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
In reclutamentoFase 3
Età da 40 a 80 · Tutti i sessi · Aggiornato il 9 apr 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
In reclutamentoFase 4
Età 19 e oltre · Tutti i sessi · Aggiornato il 10 nov 2025 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
In reclutamento
Età 30 e oltre · Tutti i sessi · Aggiornato il 6 feb 2025 · NCT05204888Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.